ESOPHAGEAL SQUAMOUS CARCINOMA CELL

Clinical trials for ESOPHAGEAL SQUAMOUS CARCINOMA CELL explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGEAL SQUAMOUS CARCINOMA CELL trials appear

Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CARCINOMA CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental fusion protein aims to re-engage immune system against tough esophageal cancer

Disease control Not yet recruiting

This phase 2 trial tests a single drug called PD-1/IL-2α-bias bispecific antibody fusion protein in people with advanced or metastatic esophageal squamous cell carcinoma whose cancer worsened after prior immunotherapy and chemotherapy. The drug is designed to boost the immune sys…

Matched conditions: ESOPHAGEAL SQUAMOUS CARCINOMA CELL

Phase: PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

ESOPHAGEAL SQUAMOUS CARCINOMA CELL

Get alerted when new ESOPHAGEAL SQUAMOUS CARCINOMA CELL trials appear

Experimental fusion protein aims to re-engage immune system against tough esophageal cancer